FURTHER EVIDENCE THAT ACTIVATED PROTEIN-C RESISTANCE CAN BE MISDIAGNOSED AS INHERITED FUNCTIONAL PROTEIN-S DEFICIENCY

被引:49
作者
COOPER, PC
HAMPTON, KK
MAKRIS, M
ABUZENADAH, A
PAUL, B
PRESTON, FE
机构
[1] ROYAL HALLAMSHIRE HOSP,DEPT HAEMATOL,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND
[2] BASSETLAW HOSP,DEPT HAEMATOL,WORKSOP,ENGLAND
关键词
APC RESISTANCE; PROTEIN S; THROMBOPHILIA; VENOUS THROMBOSIS;
D O I
10.1111/j.1365-2141.1994.tb04999.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A recent report that activated protein C (APC) resistance interferes with functional protein S (PS) assays prompted us to re-investigate two pedigrees previously diagnosed as having functional PS deficiency. APC resistance was demonstrated in all individuals with apparent functional PS deficiency. The latter diagnosis was shown to be due to the assay being non-linear. functional protein S becoming normal at higher dilutions. This observation, taken in conjunction with results of in vitro recovery studies with purified PS, leads us to conclude that APC resistance was the primary disorder in both pedigrees. The misdiagnosis of APC resistance as functional PS deficiency can be prevented by performing the PS assay at several dilutions, including concentrations lower than those recommended by PS assay manufacturers. Subjects previously diagnosed as having functional PS deficiency should be re-investigated for APC resistance.
引用
收藏
页码:201 / 203
页数:3
相关论文
共 50 条
  • [21] PROTEIN-C AND PROTEIN-S IN PATIENTS WITH ADVANCED PROSTATIC-CANCER
    OLIVEIRA, PD
    OLIVEIRA, MG
    PINA, F
    ANDRADE, JA
    PINACABRAL, JM
    THROMBOSIS RESEARCH, 1991, 63 (01) : 195 - 200
  • [22] RESISTANCE TO ACTIVATED PROTEIN-C DUE TO MUTATED FACTOR-V AS A NOVEL CAUSE OF INHERITED THROMBOPHILIA
    DESTEFANO, V
    LEONE, G
    HAEMATOLOGICA, 1995, 80 (04) : 344 - 356
  • [23] A CHROMOGENIC ASSAY FOR ACTIVATED PROTEIN-C RESISTANCE
    VARADI, K
    MORITZ, B
    LANG, H
    BAUER, K
    PRESTON, E
    PEAKE, I
    RIVARD, GE
    KEIL, B
    SCHWARZ, HP
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (04) : 884 - 891
  • [24] EFFECT OF HEMODIALYSIS ON PROTEIN-C, PROTEIN-S, AND ANTITHROMBIN-III LEVELS
    LAI, KN
    YIN, JA
    YUEN, PMP
    LI, PKT
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (01) : 38 - 42
  • [25] EFFECTS OF ANNEXIN-V ON THE ACTIVITY OF THE ANTICOAGULANT PROTEIN-C AND PROTEIN-S
    SUN, J
    BIRD, P
    SALEM, HH
    THROMBOSIS RESEARCH, 1993, 69 (03) : 279 - 287
  • [26] LOW PROTEIN-C AND PROTEIN-S AND ACTIVATION OF FIBRINOLYSIS IN TREATED ESSENTIAL THROMBOCYTHEMIA
    WIECZOREK, I
    MACGREGOR, IR
    LUDLAM, CA
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 49 (04) : 277 - 281
  • [27] RESISTANCE TO ACTIVATED PROTEIN-C IN HEALTHY WOMEN TAKING ORAL-CONTRACEPTIVES
    OLIVIERI, O
    FRISO, S
    MANZATO, F
    GUELLA, A
    BERNARDI, F
    LUNGHI, B
    GIRELLI, D
    AZZINI, M
    BROCCO, G
    RUSSO, C
    CORROCHER, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) : 465 - 470
  • [28] Diagnosis and clinical characteristics of inherited activated protein C resistance
    Samama, MM
    Simon, D
    Horellou, MH
    Trossaert, M
    Elalamy, I
    Conard, J
    HAEMOSTASIS, 1996, 26 : 315 - 330
  • [29] THE FIBRINOLYTIC SYSTEM AND PROTEIN-C AND PROTEIN-S IN TREATED POLYCYTHEMIA-RUBRA-VERA
    WIECZOREK, I
    MACGREGOR, IR
    PRESCOTT, RJ
    LUDLAM, CA
    BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (06) : 823 - 826
  • [30] PROTEIN-S AND PROTEIN-C LEVEL CHANGES WITH ADJUVANT TAMOXIFEN THERAPY IN POSTMENOPAUSAL WOMEN
    MAMBY, CC
    LOVE, RR
    FEYZI, JM
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (03) : 311 - 314